Many institutions and funds will now start to accumulate in force. Many were waiting for 1040 news because of the likelihood of negative results. Now it is all about 8040!! and 5010 to some extent. Lets not forget celiac disease and a few others!!
I like the Roth reiteration announced July 15:
"BLRX partner, Bellerophon (BLPH-NC), provided a preview BL-1040 report regarding the upcoming data release from the CE Mark registration PRESERVATION I study expected in the coming weeks with formal presentation at the European Society of Cardiology meeting in London on September 1st. We are optimistic regarding study outcomes and recommend accumulation of BLRX shares prior to data release."
However, I am concerned (and super excited) a bit about the wording here. Specifically, what was this preview BL-1040 report about? I cannot find this report anywhere in the filings or by google. And, if they only gave it to Roth, then wouldn't that be an illegal insider information leak? Maybe not if they are not trading on it and only giving advice.
on this board I think. AVXL has only a 70 million market cap and the best alzeimers candidate out there
Talk about a future blockbuster!! only a penny stock now so huge upside
Thing is. this is a chinese company not listed in China and never participated in the chinese stock run up to begin with. Does not deserve to be hit like this. In fact, fundamentals were extremely underpriced even at 13
yes. wrong word. smartsassss. I EXPECT 1,890,450,000 in revenue for year 2019. Have you seen the pipeline and looked at the market and analyzed the target market for BLRX? I have
Yes I have. I owned a small biotech a while back and had a stop loss order. My stop was taken out at 5.37 even though the shares officially traded at a low of 5.44 for the day. The time it was taken out, the bid and ask were 5.45 - 5.47. They snuck in and took it. Tried to complain to Sharebuilder but nothing
6.2 million in revenue for next quarter. That must be from BLPH and also possibly Novartis. Next year, revenue is expected up to 50 million with 0.39 profit. By 2019 i suspect over a billion in yearly revenue.
they will always figure a way to take them out.
I think there are still some traders left that were caught with the spike to 3.1. They had no intention of investing in BLRX and our moving out slowly. I am sure that almost all are gone. Who else would sell?? 99% of people buying BLRX now are INVESTING in the long term prospects.
These pric(&s still have shares that they are unloading and we need Broadfin and others to start absorbing them above 2
Revenues projections are key. One analyst has 42 million estimate for 2016, which suggests a strong belief in products beginning to hit the market for BLRX - a HUGE milestone! Focus on 8040 results and possible drug development with Novartis too
Nasdaq site for institutional ownership. Way more updated than Yahoo finance
Morgan Stanley, Deutsch Bank and Millenium all heavily increasing or starting BIG positions!! 1.5 million shares